Skip to content
Close menu

SBRI HEALTHCARE

Fraunhofer UK Research

Find a company

Over-prescription of needless antibiotics is fuelling the rising tide of antimicrobial resistance that threatens to render current antibiotics ineffective. We propose a rapid, highly-compact, non-specialist operator and low-cost device for use in primary healthcare, enabling GPs to immediately diagnose bacterial infections and their antibiotic susceptibility. This will lead to a step-change improvement in informed, targeted prescriptions; saving lives, money and time, as well as slowing resistance. Our technology uniquely brings together nanophotonic waveguides and microfluidics to determine the response of bacteria to minute quantities of antibiotics. In this Phase 1 proposal we will demonstrate proof-of-principle, working closely with GP end-users.

Project NIRASA: Nanophotonic Interferometer for Rapid Antibiotic Susceptibility Assessment
Description

Over-prescription of needless antibiotics is fuelling the rising tide of antimicrobial resistance that threatens to render current antibiotics ineffective. We propose a rapid, highly-compact, non-specialist operator and low-cost device for use in primary healthcare, enabling GPs to immediately diagnose bacterial infections and their antibiotic susceptibility. This will lead to a step-change improvement in informed, targeted prescriptions; saving lives, money and time, as well as slowing resistance. Our technology uniquely brings together nanophotonic waveguides and microfluidics to determine the response of bacteria to minute quantities of antibiotics. In this Phase 1 proposal we will demonstrate proof-of-principle, working closely with GP end-users.

Funding £ 826,740
Competition Competition 12 - General Practice of the Future
Competition Date November 2016
Website https://www.fraunhofer.co.uk/

Subscribe

Subscribe to the SBRI Healthcare newsletter and receive the latest competition information & latest news updates.